Crossmark

TPX2/Aurora kinase A signaling as a potential therapeutic target in genomically unstable cancer cells

Crossref DOI link: https://doi.org/10.1038/s41388-018-0470-2

Published Online: 2018-09-03

Published Print: 2019-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

van Gijn, Stephanie E.

Wierenga, Elles

van den Tempel, Nathalie

Kok, Yannick P.

Heijink, Anne Margriet

Spierings, Diana C. J.

Foijer, Floris https://orcid.org/0000-0003-0989-3127
van Vugt, Marcel A. T. M.

Fehrmann, Rudolf S. N. https://orcid.org/0000-0002-7516-315X
Funding

Funding for this research was provided by:

KWF Kankerbestrijding (Dutch Cancer Society) (RUG 2011-5093, RUG 2012-5549)

Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Netherlands Organisation for Scientific Research) (NWO-VIDI 917-13334, NWO-VENI 916-16025)

EC | European Research Council (ERC) (ERC-CoS Tension)
License Information

Text and Data Mining valid from 2018-09-03
More Information

Article History

Received: 2 February 2018

Revised: 30 June 2018

Accepted: 30 July 2018

First Online: 3 September 2018

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.